v3.26.1
Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
Common Stock [Member]
Preferred Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2023 $ 200 $ 51,555,452 $ (47,481,836) $ 4,073,816
Balance, shares at Dec. 31, 2023 1 200,000      
Series A compensation expense 656,250 656,250
Conversion of notes payable into common stock 209,819 209,819
Net loss (17,604,364) (17,604,364)
Issuance of Series D preferred stock for liabilities settlement $ 312 2,167,814 2,168,126
Issuance of Series D preferred stock for liabilities settlement, shares   312,412      
Issuance of Series D preferred stock $ 32 433,576 433,608
Issuance of Series D preferred stock, shares   31,500      
Issuance of common stock for liabilities settlement 875,652 875,652
Issuance of common stock 143,717 143,717
Issuance of warrants for liabilities settlement 1,411,607 1,411,607
Conversion of Series A preferred stock into common stock 4 4
Conversion of Series A preferred stock into common stock, shares   (188)      
Conversion of Series D preferred stock into common stock $ (145) 13 (132)
Conversion of Series D preferred stock into common stock, shares 1 (145,468)      
Exercise of pre-funded warrants into common stock 8 8
Effect of reverse stock split round lot shares 8 8
Balance at Dec. 31, 2024 $ 398 57,453,920 (65,086,200) (7,631,882)
Balance, shares at Dec. 31, 2024 2 398,256      
Series A compensation expense 531,251 531,251
Conversion of Series A preferred stock to common stock $ (2) 1,399 1,397
Conversion of Series A preferred stock to common stock, shares 18 (1,606)      
Exercise of warrants 11,970 11,970
Exercise of warrants, shares 33      
Issuance of Series D preferred stock and common Stock for liabilities settlement $ 477 10,056,837 10,057,315
Issuance of Series D preferred stock and common Stock for liabilities settlement, shares 255 477,385      
Issuance of common stock and Series D preferred stock for consulting services $ 30 592,470 592,499
Issuance of common stock and Series D preferred stock for consulting services, shares 13 29,667      
Issuance of common stock in private placement 2,500,000 2,500,000
Issuance of common stock in private placement, shares 12        
Issuance of common stock in connection with consulting and financing arrangement 2,205 2,205
Conversion of Series D preferred Stock to common stock $ 1 $ (523) 522
Conversion of Series D preferred Stock to common stock, shares 783 (523,116)      
Conversion of notes payable into common stock 21,060,691 21,060,691
Conversion of notes payable into common stock, shares 194        
Common stock and warrants issued for minority interest investment 1,999,850 1,999,851
Common stock and warrants issued for minority interest investment, shares 21        
Series E preferred stock issued in connection with Damon Note $ 2 1,999,998 2,000,000
Series E preferred stock issued in connection with Damon Note, shares   2,000      
Series D preferred stock issued for asset acquisition $ 632 4,738,548 4,739,180
Series D preferred stock issued for asset acquisition, shares   632,134      
Issuance of common stock and Series D preferred stock for services to be performed $ 168 1,257,340   1,257,508
Issuance of common stock and Series D preferred stock for services to be performed, shares   167,688      
Issuance of Series D preferred stock $ 339 2,188,417 2,188,756
Issuance of Series D preferred stock, shares   339,293      
Conversion of notes payable into common stock (607,748) (607,748)
Effect of reverse stock split round lot shares $ 2 4,064 4,066
Effect of reverse stock split round lot shares, shares 2,031      
Net loss (34,325,289) (34,325,289)
Balance at Dec. 31, 2025 $ 3 $ 1,521 $ 103,791,736 $ (99,411,489) $ 4,381,771
Balance, shares at Dec. 31, 2025 3,362 1,521,701